Uh-oh! This study is no longer available.
Pneumonia Vaccine – Ages 65+
PMG Research of Winston Salem
65 or older
A research study is evaluating an investigational vaccine compared to Prevnar 13™ for prevention of pneumococcal disease in adults 50 and older.
This research study may be an option if you:
• Are generally healthy
• Have not received a previous pneumonia vaccine
• Have not tested positive for pneumonia in the last 3 years
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and study medication or Prevnar 13™ at no cost.
Patient Commitment Duration
Approximately 6 months
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 2 clinic visits and 2 phone calls